Blinatumomab for Acute Lymphoblastic Leukemia

Jinichi Mori^{1

2}, Kumi Oshima¹, Tetsuya Tanimoto³

Affiliations

Comment

Jinichi Mori et al. N Engl J Med. 2017.

. 2017 Jun 8;376(23):e49.

doi: 10.1056/NEJMc1704012.

Jinichi Mori^{1

2}, Kumi Oshima¹, Tetsuya Tanimoto³

No abstract available

Comment in

Blinatumomab for Acute Lymphoblastic Leukemia.
Kantarjian H, Jabbour E, Topp MS. Kantarjian H, et al. N Engl J Med. 2017 Jun 8;376(23):e49. doi: 10.1056/NEJMc1704012. N Engl J Med. 2017. PMID: 28591537 No abstract available.

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
Kantarjian H, Stein A, Gökbuget N, Fielding AK, Schuh AC, Ribera JM, Wei A, Dombret H, Foà R, Bassan R, Arslan Ö, Sanz MA, Bergeron J, Demirkan F, Lech-Maranda E, Rambaldi A, Thomas X, Horst HA, Brüggemann M, Klapper W, Wood BL, Fleishman A, Nagorsen D, Holland C, Zimmerman Z, Topp MS. Kantarjian H, et al. N Engl J Med. 2017 Mar 2;376(9):836-847. doi: 10.1056/NEJMoa1609783. N Engl J Med. 2017. PMID: 28249141 Free PMC article. Clinical Trial.